We highly recommend reading the article below for more information on the key risks and interactions of GLP-1 receptor agonists
Common outcomes include: Gradual and sustainable weight loss Noticeable appetite reduction Improved portion control Fewer cravings Better metabolic stability Oral GLP-1 therapy is not one-size-fits-all
This has several downstream effects: slower gastric emptying (food stays in the stomach longer, extending fullness), reduced appetite signalling in the hypothalamus, and improved insulin sensitivity, which helps stabilize blood sugar and reduce cravings linked to glucose spikes and crashes
But for these antioxidants to work at their full potential, hydration is non-negotiable
the pharmacy side working and the health system side all being able to process these prior authorizations in an efficient, effective way, said Dr Annie Moore, an internist at CU Health in Denver